Goldman Sachs Not Convinced Clorox (CLX) Q2 'Beat' was Real
Goldman Sachs bumped estimates and its price target on Clorox (NYSE: CLX) higher following Q2 results which easily beat the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
